← Back to headlines
Novartis' Pluvicto Receives Expanded Indication
Pharmaceutical company Novartis has announced that its cancer drug, Pluvicto, has received an expanded indication, allowing it to be used for a broader patient population or condition.
31 Jul, 21:26 — 31 Jul, 21:26
Sources
Showing 1 of 1 sources
